GCWB1001 Evaluates the Effectiveness and Safety of Respiratory Health
NCT05544942 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120
Last updated 2026-02-23
Summary
This human application test was designed to evaluate the effectiveness and safety of the losing suction tendon, compared to the control food when the GCWB1001 was consistent with the symptoms of the respiratory symptoms of mildness.
Conditions
- Respiratory Symptoms
Interventions
- DIETARY_SUPPLEMENT
-
Lactobacillus plantarum
1 capsule once a day
- OTHER
-
maltodextrin
1 capsule once a day
Sponsors & Collaborators
-
Green Cross Wellbeing
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 20 Years
- Max Age
- 69 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-08-23
- Primary Completion
- 2023-08-30
- Completion
- 2023-08-31
Countries
- South Korea
Study Locations
More Related Trials
-
Washing Pipe with a Spray Nozzle for Topical Anesthesia During Bronchoscopy
NCT05970848 ·Status: COMPLETED ·Phase: NA
-
A Study to Test the Safety and Effects of Inhaled GDC-6988 in Participants With Muco-obstructive Disease
NCT06603246 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
A Clinical Trial to Evaluate the Efficacy and Safety of YMC026 in Respiratory Disease Patients
NCT03334916 ·Status: COMPLETED ·Phase: PHASE4
-
Phase I Study of CPD704 Inhalation Suspension in Healthy Subjects
NCT07301203 ·Status: RECRUITING ·Phase: PHASE1
-
Placebo-controlled, Single and Multiple Dose Study in Healthy Volunteers and Refractory Chronic Cough Patients to Assess the Safety, Tolerability, and Pharmacokinetics of Two Formulations of NTX-1175
NCT05628740 ·Status: COMPLETED ·Phase: PHASE1
-
Study of the Efficacy and Safety of SCH 619734 in Subjects With Chronic Cough From an Unknown Cause (Study P04888)
NCT00506545 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Trial to Evaluate the Safety and Efficacy of "Theobromine Capsule" as an Antitussive in Acute Cougher
NCT01416480 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Assess the Effectiveness and Safety of GSK3862995B in Adults With Bronchiectasis
NCT07201051 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Live Vaccines and Innate Immune Training in COPD.
NCT06257212 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of RTB101 on Illness Associated With Respiratory Tract Infections in the Elderly
NCT04139915 ·Status: WITHDRAWN ·Phase: PHASE3
-
Phase III Randomized Study of the Inhalation of Tobramycin in Patients With Cystic Fibrosis
NCT00004829 ·Status: COMPLETED ·Phase: PHASE3
-
The Safety, Tolerability and Pharmacokinetic Study of HEC68498 in Healthy Male and Female Subjects
NCT03502902 ·Status: COMPLETED ·Phase: PHASE1
-
The Safety of Tuberculosis Treatments by Oral Inhalation
NCT01785927 ·Status: UNKNOWN ·Phase: PHASE1
-
A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of GlaxoSmithkline (GSK) Biologicals' Investigational Vaccine GSK2838504A When Administered to Chronic Obstructive Pulmonary Disease (COPD) Patients With Persistent Airflow Obstruction.
NCT02075541 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy of Oral BAY85-8501 in Patients With Non-CF (Cystic Fibrosis) Bronchiectasis
NCT01818544 ·Status: COMPLETED ·Phase: PHASE2
-
Study Evaluating Fosfomycin/Tobramycin for Inhalation in Cystic Fibrosis Patients With Pseudomonas Aeruginosa Lung Infection
NCT00794586 ·Status: COMPLETED ·Phase: PHASE2
-
A Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GNS-3545 in Healthy Participants
NCT07225296 ·Status: RECRUITING ·Phase: PHASE1
-
Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment
NCT01695343 ·Status: COMPLETED ·Phase: PHASE2
-
Pharmacokinetic Evaluation and Tolerability of Dry Powder Tobramycin by a Novel Device in Patients With Non Cystic Fibrosis Bronchiectasis
NCT02035488 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of GSK3862995B Administered as a Single Dose to Healthy Participants of Chinese, Japanese, and European Ancestry
NCT06979518 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
Safety and Efficacy of Umbilical Cord Mesenchymal Stem Cell Exosomes in Treating Chronic Cough After COVID-19
NCT05808400 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Lidocaine: Effect of Lidocaine in Chronic Cough
NCT01252225 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Access Safety and Efficacy of Nebulized Tobramycin in Patients With Bronchiectasis
NCT01677403 ·Status: UNKNOWN ·Phase: PHASE4
-
A Study to Test the Efficacy and Safety of Inhaled GB0139 in Subjects With Idiopathic Pulmonary Fibrosis (IPF)
NCT03832946 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase II, Randomized, Double-blind, Placebo-controlled Study to Examine the Effects of DAS181 in Immunocompromised Subjects With Lower Respiratory Tract Parainfluenza Infection on Supplemental Oxygen
NCT01644877 ·Status: COMPLETED ·Phase: PHASE2